Citalopram

Human Psychopharmacology

Volumn 15, Issue 6, 2000, Pages 439-451

  Charlier, C ^a,b   Pinto, E ^a   Ansseau, M ^a   Plomteux, G ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b CHU SART TILMAN   (Belgium)

Author keywords

Anxiety; Citalopram; Depression; Elderly depression; OCD; Panic

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; LITHIUM; NEUROLEPTIC AGENT; PAROXETINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN;

DEPRESSION; DRUG CHOICE; DRUG EFFICACY; DRUG INDICATION; DRUG SPECIFICITY; DRUG STRUCTURE; GERIATRIC CARE; HUMAN; INSOMNIA; LONG TERM CARE; NAUSEA; NONHUMAN; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; REVIEW; SOMNOLENCE; TRANQUILIZING ACTIVITY; XEROSTOMIA;

EID: 0033822036     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1077(200008)15:6<439::AID-HUP222>3.0.CO;2-H     Document Type: Review

References (94)

1. Citalopram for post-stroke pathological crying
2. Effective treatment of post-stroke depression with the selective serotonin re-uptake inhibitor citalopram
3. Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics
4. Tricyclic antidepressant plasma levels after augmentation with citalopram: A case study
5. The side effect burden associated with drug treatment of panic disorder
6. SSRI safety in overdose
7. Pharmacodynamic and pharmacokinetic interactions of selective serotonin reuptake inhibiting antidepressants (SSRIs) with other psychotropic drugs
8. The pharmacokinetics of citalopram
9. Clinical properties of citalopram in comparison with other antideressants: A quantitative meta-analysis
10. Citalopram treatment of obsessive compulsive disorder: A pilot study of antiobsessive efficacy
11. Therapeutical aspects of using citalopram in burns
12. Citalopram and fluoxetine in major depression: Comparison of two clinical trials in a psychiatrist setting and in general practice
13. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalised social phobia
14. Potential indications for the selective serotonin reuptake inhibitors
15. Metabolism and excretion of citalopram in man: Identification of O-acyl- and N-glucuronides
16. The place of selective serotonin reuptake inhibitors in the treatment of panic disorder
17. Citalopram versus mianserin. A controlled, double-blind trial in depressed patients
18. Changes in personality traits during treatment with sertraline or citalopram
19. A double-blind, multi-centre trial comparing sertraline and citalopram in patients with major depression treated in general practice
20. Multi-center, placebo-controlled, fixed-dose study of citalopram in moderate to severe depression
21. Citalopram: A review of pharmacology and clinical efficacy
22. Kinetics of citalopram in man: Plasma levels in patients
23. Kinetics of citalopram in elderly patients
24. Citalopram: Interaction studies with levomepromazine, imipramine, and lithium
25. Drug interactions with newer antidepressants: Role of human cytochromes P450
26. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: A double-blind, multi-centre study
27. Serotonin, panic disorder and agoraphobia: Short-term and long-term efficacy of citalopram in panic disorders
28. Citalopram: Pharmacological profile of a specific serotonin up-take inhibitor with antidepressant activity
29. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
30. Serotonin-selective anti-depressants
31. The pharmacology of citalopram
32. Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing
33. Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects
34. Citalopram and anxiety disorders
35. Comparative efficacy of antidepressant drugs
36. Citalopram in the treatment of obsessive-compulsive disorder. A report of two cases
37. Citalopram in the treatment of obsessive-compulsive disorder: An open-pilot study
38. The kinetics of citalopram: Single and multiple dose studies in man
39. A comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice
40. The effects of citalopram in single and repeated doses and with alcohol on physiological and psychological measures in healthy volunteers
41. Lack of adverse interactions between concomitantly administered selegiline and citalopram
42. Citalopram in the treatment of social phobia: A report of three cases
43. The effect of citalopram in panic disorder and agora-phobia. A pilot study
44. Citalopram in the treatment of early-onset panic disorder and school phobia
45. A controlled prospective one year trial with citalopram in the treatment of panic disorder
46. Double-blind comparison of citalopram and placebo in depressed out-patients with melancholia
47. C[talopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness
48. 5-HT reuptake inhibitors in the treatment of depression
49. Citalopram in the treatment of depression
50. A 24-week study of 20 mg citalopram, 40 mg citalopram and placebo in the prevention of relapse of major depression
51. The optimal dosing regime for citM alopram - A meta-analysis of nine placebo-controlled studies
52. Efficacy of fluvoxamine, paroxetine and citalopram in the treatment of obsessive-compulsive disorder: A single blind study
53. The serotonin uptake inhibitor citalopram attenuates ethanol intake
54. Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers
55. Using fuzzy logic to predict response to citalopram in alcohol dependence
56. Five fatal cases of serotonin syndrome after meclobomide-citalopram or meclobomide-clomipramine overdoses
57. Citalopram. A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression
58. Scandinavian trial of citalopram versus placebo in elderly depressed patients
59. Citalopram versus fluoxetine: A double-blind, controlled, multi-centre, phase III trial in patients with unipolar major depression treated in general practice
60. Citalopram toxicity
61. Behavioural despair in mice: A primary screening test for anti-depressants
62. Pharmacokinetic interaction study of citalopram and clmetidine in healthy subjects
63. Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin
64. The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression
65. Long-term treatment of elderly individuals with emotional disturbances: An open study with citalopram
66. The cardiac safety of citalopram: Prospective trials and retrospective analyses
67. Citalopram in doses of 20-60 mg is effective in depression relapse prevention: A placebo-controlled 6 month study
68. Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box
69. Isolation-induced aggression in mice: Effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HTIA receptors
70. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding
71. Behavioural profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
72. A comparison of the antidepressant action of citalopram and amitriptyline
73. The role of SSRIs in panic disorder
74. Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans
75. Use of the serotonin selective reuptake inhibitor citalopram in obsessive-compulsive disorder
76. Citalopram causes no significant alterations in plasma neuroleptic levels in schizophrenic patients
77. Child and adolescent obsessive-compulsive disorder treated with citalopram: Findings from an open trial of 23 cases
78. Citalopram in the treatment of alcoholism: A double-blind placebo-controlled study
79. Citalopram-lithium combination treatment of elderly depressed patients: A pilot study
80. Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia
81. Clinical pharmacokinetics of antidepressants in the elderly - Therapeutic implications
82. Citalopram and desmethylcitalopram in vitro: Human cytochromes mediating transformation, and cytochrome inhibitory effects
83. The effect of citalopram in panic disorder
84. Serotonin-uptake inhibitors in obsessive-compulsive disorder: A case report
85. Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?
86. Chronic mild stress-induced anhedonia: A realistic animal model of depression